← Back
$XENE All transactions

Xenon Pharmaceuticals Inc.

A

$ Value

$0

Shares

225,000

Price

$0

Filed

Oct 17

Insider

Name

Kelly Thomas Patrick

Title

Chief Financial Officer

CIK

0001410514

Roles

Officer

Transaction Details

Transaction Date

2025-10-15

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

225,000

Footnotes

Vesting 25% on October 15, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. | Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.

Filing Info

Accession No.

0001193125-25-242700

Form Type

4

Issuer CIK

0001582313

Kelly Thomas Patrick's History

Date Ticker Type Value
2025-10-15 XENE A $0
2025-10-15 XENE A $0

Other Insiders at XENE (90d)

No other insider activity at this issuer in the last 90 days.